Hubei Shizhen Laboratory

2 months ago | nutritionandmetabolism.biomedcentral.com | Hubei Shizhen Laboratory

Preliminary to this study, we conducted a rigorous screening of 4,286 faculty and staff members who had undergone health checks at a university in Hubei from 2021 to 2023, including anthropometric measures, blood tests, and biochemical assessments. To explore potential factors, we conducted comprehensive analyses, utilizing an array of methods to identify the causal relationships and risk factors. This study was approved by the research institution’s ethics committee.

Nov 27, 2024 | link.springer.com | Hubei Shizhen Laboratory

AbstractIn an aging society, depression has become a public health challenge that can lead to many adverse health outcomes; evidence addressing the link between depression and motor cognitive risk syndrome (MCR, a novel syndrome that effectively predicts dementia) is still lacking. A PRISMA checklist was used to systematically review the relevant peer-reviewed literature for the primary data analysis.

Sep 4, 2024 | bmcgenomics.biomedcentral.com | Hubei Shizhen Laboratory

P. ternata “Yingshan” specimens were collected on April 25, 2022, at Hubei University of Chinese Medicine and authenticated by Prof. Liu Dahui (voucher No. Yingshan202204), and stored in the medical plants garden of Hubei University of Chinese Medicine. Tissue culture seedlings were acclimated for 15 days in floating dishes, then transferred to pots and grown under controlled conditions (24 °C; 12 h of light/12 hours of dark; 60% humidity) for 30 days. P. carotovorum QJ-1 and P.

Aug 27, 2024 | cancerci.biomedcentral.com | Hubei Shizhen Laboratory

The human TSCC cell lines CAL27 (CRL-2095) and SCC9 (CRL-2095) were obtained from the American Type Culture Collection (ATCC). HN6 cells were gifted by the Stomatological Hospital Affiliated to Shanxi Medical University. The HN6 and CAL27 cell lines were cultured in DMEM high-glucose medium (Biosharp Life Sciences, CN, BL304A) containing 10% fetal bovine serum (FBS) (Jitai Excellbio Biotechnology, FSP500) and 1% penicillin and streptomycin (Biosharp Life Sciences, BL505A).

Jul 29, 2024 | onlinelibrary.wiley.com | Lin Zhang |Hubei Shizhen Laboratory |Kai Zhang |Fang Yang

Corresponding Author Lin ZHANG Hubei Shizhen Laboratory, Hubei Key Laboratory of Theory and Application Research of Liver and Kidney in Traditional Chinese Medicine, School of Basic Medical Sciences, Hubei University of Chinese Medicine, Wuhan, China Lin Zhang and Kai Zhang contributed equally to this work. Correspondence: Lin Zhang, Hubei University of Chinese Medicine, Wuhan 430065, China.